This contrasts with an earlier study that reported cannabidivardin improved symptoms (anxiety behaviour not assessed) in Mecp2 null mice (Vigli et al., 2018), so it is possible that cannabinoid receptors may be relevant to anxiety in Rett syndrome. The gene discussed is MECP2; the disease is atypical Rett syndrome.